| 1 |
35345991 | The effects of curcumin supplementation on metabolic biomarkers and body mass index in patients with nonalcoholic fatty liver disease, a systematic review and meta-analysis of randomized controlled trials. | 2022 Mar 28 |
1 |
| 2 |
33861434 | The Effect of Curcumin Phytosome on the Treatment of Patients with Non-alcoholic Fatty Liver Disease: A Double-Blind, Randomized, Placebo-Controlled Trial. | 2021 |
2 |
| 3 |
34758851 | Curcumin prevents As3+-induced carcinogenesis through regulation of GSK3β/Nrf2. | 2021 Nov 10 |
4 |
| 4 |
30446932 | The effects of curcumin on the metabolic parameters of non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials. | 2019 May |
1 |
| 5 |
31183386 | Curcumin and α/β-Adrenergic Antagonists Cotreatment Reverse Liver Cirrhosis in Hamsters: Participation of Nrf-2 and NF-κB. | 2019 |
1 |
| 6 |
29806132 | An investigation of the effects of curcumin on iron overload, hepcidin level, and liver function in β-thalassemia major patients: A double-blind randomized controlled clinical trial. | 2018 Sep |
2 |
| 7 |
23143785 | Therapeutic roles of curcumin: lessons learned from clinical trials. | 2013 Jan |
1 |